Acquisition by Stuart Drummond of 2949 shares of Cutera at 1.54 subject to Rule 16b-3
| CUTR Stock | USD 0.41 0.03 6.82% |
Slightly above 61% of Cutera's investor base is looking to short. The analysis of overall sentiment of trading Cutera Inc stock suggests that many investors are alarmed at this time. Cutera's investing sentiment overview a quick insight into current market opportunities from investing in Cutera Inc. Many technical investors use Cutera Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Cutera |
Filed transaction by Cutera Inc Officer Interim Cfo. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Cutera Fundamental Analysis
We analyze Cutera's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cutera using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cutera based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Cutera is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Cutera Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cutera stock to make a market-neutral strategy. Peer analysis of Cutera could also be used in its relative valuation, which is a method of valuing Cutera by comparing valuation metrics with similar companies.
Peers
Cutera Related Equities
| NPCE | Neuropace | 5.67 | ||||
| ITGR | Integer Holdings | 1.72 | ||||
| LUNG | Pulmonx Corp | 1.23 | ||||
| KIDS | Orthopediatrics Corp | 0.96 | ||||
| OFIX | Orthofix Medical | 0.16 | ||||
| ELMD | Electromed | 0.03 | ||||
| SRDX | SurModics | 0.30 | ||||
| FNA | Paragon 28 | 0.87 | ||||
| LIVN | LivaNova PLC | 1.28 | ||||
| CNMD | CONMED | 1.36 | ||||
| INGN | Inogen | 1.68 | ||||
| SIBN | Si Bone | 2.62 | ||||
| CVRX | CVRx | 3.09 | ||||
| APYX | Apyx Medical | 13.16 |
Additional Tools for Cutera Stock Analysis
When running Cutera's price analysis, check to measure Cutera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cutera is operating at the current time. Most of Cutera's value examination focuses on studying past and present price action to predict the probability of Cutera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cutera's price. Additionally, you may evaluate how the addition of Cutera to your portfolios can decrease your overall portfolio volatility.